Wednesday, October 04, 2023 9:03:55 PM
I'm not sure if David resigned though, it sounded more to me that he was removed by the BOD.
Could it be possible that the BOD ousted Epstein on account of finding out about his relationship with PairX?.. and to the extent of licensing ip!!
https://www.pairxbio.com/post/duke-nus-spinout-pairx-bio-launches-with-strong-biotech-credentials-venture-capital-backing
"“I am delighted that Duke-NUS, Esco Ventures, Avendesora and the PairX founding team are partnering to commercialise our platform and pipeline of novel cancer antigen–T cell pairs. This seed financing uniquely positions PairX to advance precision immunotherapies designed to treat cancer patients defined by shared mRNA splicing defects,”
- Adj Assoc Prof Epstein
Theory: BOD saw this
https://www.biospectrumasia.com/news/54/16545/pairx-bio-launches-venture-capital-backing-targeting-cancer-immunotherapies.html
contacted David - "your fired".
(imo though, PairX is cutting edge in the TCR-T category and Epstein sees the future of this)
Recent BDTX News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/13/2024 11:09:49 PM
- Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:13:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:10:51 AM
- Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- Black Diamond Therapeutics Announces Changes to Board of Directors • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/07/2024 10:00:00 PM
- Black Diamond Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 03/11/2024 05:14:39 PM
- Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:45:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:36:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:35:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:34:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:04:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:07:08 PM
- Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 12:08:08 PM
- Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM • GlobeNewswire Inc. • 12/13/2023 12:00:00 PM
- Black Diamond Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/06/2023 12:45:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 12:14:57 PM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM